Is Wall Street Bullish or Bearish on DaVita Stock?

Based in Denver, Colorado, DaVita Inc. (DVA) is a prominent U.S. provider of dialysis services for patients with chronic kidney failure or end-stage renal disease (ESRD). Valued at $13.1 billion by market cap, the company also operates a diverse ancillary services segment, offering international dialysis services, pharmacy and infusion therapy, disease management, vascular access, ESRD clinical research, and physician support.

Shares of the kidney specialist have exceeded the broader market over the past year. While DVA stock has surged 69.7% over this time frame, the S&P 500 Index ($SPX) has rallied by 30.4%. In 2024 alone, the stock rose 53.1%, compared to SPX’s 23.1% return on a YTD basis.